Intra-Cellular Therapies Inc. buy Cantor Fitzgerald
Start price
29.03.23
/
50%
€52.40
Target price
29.03.24
€80.23
Performance (%)
22.14%
End price
30.03.24
€64.00
Summary
This prediction ended on 30.03.24 with a price of €64.00. The prediction had a final performance of 22.14%. Cantor_Fitzgerald has a follow-up prediction for Intra-Cellular Therapies Inc. where he still thinks Intra-Cellular Therapies Inc. is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intra-Cellular Therapies Inc. | -0.826% | -0.826% | 3.270% |
| iShares Core DAX® | -0.383% | 5.404% | 14.198% |
| iShares Nasdaq 100 | 1.248% | 6.732% | 34.022% |
| iShares Nikkei 225® | 0.525% | 1.840% | 10.062% |
| iShares S&P 500 | 0.640% | 4.710% | 27.309% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at Cantor Fitzgerald from $83.00 to $87.00. They now have an "overweight" rating on the stock.
Ratings data for ITCI provided by MarketBeat
In the thread Trading Intra-Cellular Therapies Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Current prediction by Cantor_Fitzgerald for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€51.30
03.11.23
03.11.23
€94.07
03.11.24
03.11.24
15.98%
09:38
09:38
Stopped prediction by Cantor_Fitzgerald for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€68.50
24.04.24
24.04.24
€112.30
24.04.25
24.04.25
-11.68%
09:38
09:38
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€64.80
23.02.24
23.02.24
€93.28
23.02.25
23.02.25
-6.64%
09:38
09:38
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€59.40
14.12.23
14.12.23
€91.89
14.12.24
14.12.24
1.85%
09:38
09:38